CureVac NV held its Annual General Meeting of Shareholders on June 24, 2025. During the meeting, several proposals were presented and approved. These included the adoption of the annual accounts for the financial year 2024, the release of managing directors from liability for the exercise of their duties during the financial year 2024, and the reappointment of Jean Stéphenne, Mehdi Shahidi, Debra Barker, and Klaus Schollmeier as members of the supervisory board. The meeting also approved the authorisation of the management board to issue shares and to grant rights to subscribe for shares, limit or exclude pre-emption rights, and the reappointment of the external auditor for the financial year 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.